Gleason Score News and Research

RSS
Medicare incurs more than $1.2 billion over prostate cancer care in older men

Medicare incurs more than $1.2 billion over prostate cancer care in older men

Higher doses of radiation do not translate into longer survival for prostate cancer patients

Higher doses of radiation do not translate into longer survival for prostate cancer patients

Multimodal treatment approach enhances long-term survival in men with metastatic prostate cancer

Multimodal treatment approach enhances long-term survival in men with metastatic prostate cancer

Obese men may have elevated risk of biochemical recurrence after radical prostatectomy

Obese men may have elevated risk of biochemical recurrence after radical prostatectomy

Men who follow Mediterranean diet have lower risk of aggressive prostate cancer, study finds

Men who follow Mediterranean diet have lower risk of aggressive prostate cancer, study finds

PET scans can predict prostate cancer patients’ response to salvage radiation treatment

PET scans can predict prostate cancer patients’ response to salvage radiation treatment

New CSHL method pinpoints which prostate tumors pose fatal threat before surgery

New CSHL method pinpoints which prostate tumors pose fatal threat before surgery

Common genetic fusion event could help identify patients with low-risk prostate cancer

Common genetic fusion event could help identify patients with low-risk prostate cancer

Prostate Cancer Awareness Month: Myriad Genetics working to educate public about hereditary cancer risk assessment

Prostate Cancer Awareness Month: Myriad Genetics working to educate public about hereditary cancer risk assessment

Prostate cancer screening reduces cancer deaths finds new analysis

Prostate cancer screening reduces cancer deaths finds new analysis

Surgery may not prolong life in men with early-stage prostate cancer

Surgery may not prolong life in men with early-stage prostate cancer

Prolaris becomes first genetic test to receive Medicare coverage for favorable intermediate and low-risk prostate cancer

Prolaris becomes first genetic test to receive Medicare coverage for favorable intermediate and low-risk prostate cancer

Protein testing may become potential tool to detect prostate cancer

Protein testing may become potential tool to detect prostate cancer

New genetic test may give men better view on how to deal with prostate cancer risk

New genetic test may give men better view on how to deal with prostate cancer risk

Research finds disparity in rates of prostate cancer treatment among African-American, Hispanic men

Research finds disparity in rates of prostate cancer treatment among African-American, Hispanic men

Intermediate risk prostate cancer patients can achieve survival benefit with brachytherapy alone

Intermediate risk prostate cancer patients can achieve survival benefit with brachytherapy alone

Management of prostate cancer varies by race

Management of prostate cancer varies by race

Active surveillance improves health related quality of life in low risk prostate cancer patients

Active surveillance improves health related quality of life in low risk prostate cancer patients

Changes in benign tissue adjacent to prostate tumors could better predict recurrence

Changes in benign tissue adjacent to prostate tumors could better predict recurrence

Study assesses risk factors for metastases in prostate cancer patients on active surveillance

Study assesses risk factors for metastases in prostate cancer patients on active surveillance